Literature DB >> 10567369

The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo.

B e Xu1, J L Wilsbacher, T Collisson, M H Cobb.   

Abstract

An ERK2-binding site at the N terminus of MEK1 was reported to mediate their stable association. We examined the importance of this binding site in the feedback phosphorylation of MEK1 on Thr(292) and Thr(386) by ERK2, the phosphorylation and activation of ERK2 by MEK1, and the interaction of MEK1 with ERK2 and Raf-1. Deletion of the binding site from MEK1 reduced its phosphorylation by ERK2, but had no effect on its phosphorylation by p21-activated protein kinase-1 (PAK1). A MEK1 N-terminal peptide containing the binding site inhibited MEK1 phosphorylation by ERK2. However, it did not affect MEK1 phosphorylation by p21-activated protein kinase or myelin basic protein phosphorylation by ERK2. Deletion of the N-terminal ERK-binding domain of MEK1 also reduced its ability to phosphorylate ERK2 in vitro, to co-immunoprecipitate with ERK2, and to stimulate ERK2 activation in transfected cells, but it did not alter the association with endogenous Raf-1. Using ERK2-p38 chimeras and an ERK2 deletion mutant, a MEK1-binding site of ERK2 was localized to its N terminus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567369     DOI: 10.1074/jbc.274.48.34029

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.

Authors:  A J Bardwell; L J Flatauer; K Matsukuma; J Thorner; L Bardwell
Journal:  J Biol Chem       Date:  2000-12-28       Impact factor: 5.157

2.  Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.

Authors:  S T Eblen; A D Catling; M C Assanah; M J Weber
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

3.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

4.  Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.

Authors:  Scott T Eblen; Jill K Slack; Michael J Weber; Andrew D Catling
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

5.  Cytoplasmic localization of Wis1 MAPKK by nuclear export signal is important for nuclear targeting of Spc1/Sty1 MAPK in fission yeast.

Authors:  Aaron Ngocky Nguyen; Aminah D Ikner; Mitsue Shiozaki; Sasha M Warren; Kazuhiro Shiozaki
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

Review 6.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

7.  WNK1 activates SGK1 to regulate the epithelial sodium channel.

Authors:  Bing-e Xu; Steve Stippec; Po-Yin Chu; Ahmed Lazrak; Xin-Ji Li; Byung-Hoon Lee; Jessie M English; Bernardo Ortega; Chou-Long Huang; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

8.  Selectivity of docking sites in MAPK kinases.

Authors:  A Jane Bardwell; Erlynn Frankson; Lee Bardwell
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

9.  Phosphorylation or Mutation of the ERK2 Activation Loop Alters Oligonucleotide Binding.

Authors:  Andrea C McReynolds; Aroon S Karra; Yan Li; Elias Daniel Lopez; Adrian G Turjanski; Elhadji Dioum; Kristina Lorenz; Elma Zaganjor; Steve Stippec; Kathleen McGlynn; Svetlana Earnest; Melanie H Cobb
Journal:  Biochemistry       Date:  2016-03-16       Impact factor: 3.162

Review 10.  MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms.

Authors:  Pui-Kei Wu; Jong-In Park
Journal:  Semin Oncol       Date:  2015-09-24       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.